TGM2 and autoimmune disease: Altered permeability of the intestinal barrier together with decreased expression of CFTR and increased expression/activity of TG2 observed in patients affected by CD upon gluten consumption is followed by inflammation and immune system activation, finally resulting in autoimmune disease onset.